• Something wrong with this record ?

Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019

A. Plankaova, M. Brajerova, V. Capek, G. Balikova Novotna, P. Kinross, J. Skalova, A. Soltesova, P. Drevinek, M. Krutova

. 2023 ; 62 (1) : 106824. [pub] 20230426

Language English Country Netherlands

Document type Journal Article

AIM: To investigate the epidemiology of Clostridioides difficile infection (CDI) in Slovakian hospitals after the emergence of ribotype 176 (027-like) in 2016. METHODS: Between 2018 and 2019, European Centre for Disease Control and Prevention CDI surveillance protocol v2.3 was applied to 14 hospitals, with additional data collected on recent antimicrobial use and the characterization of C. difficile isolates. RESULTS: The mean hospital incidence of CDI was 4.1 cases per 10,000 patient bed-days. One hundred and five (27.6%) in-hospital deaths were reported among the 381 cases. Antimicrobial treatment within the previous 4 weeks was recorded in 90.5% (333/368) of cases. Ribotype (RT)176 was detected in 50% (n=185/370, 14 hospitals) and RT001 was detected in 34.6% (n=128/370,13/14 hospitals) of cases with RT data. Overall, 86% (n=318/370) of isolates were resistant to moxifloxacin by Thr82Ile in GyrA (99.7%). Multi-locus variable tandem repeat analysis showed clonal relatedness of predominant RTs within and between hospitals. Seven of 14 sequenced RT176 isolates and five of 13 RT001 isolates showed between zero and three allelic differences by whole-genome multi-locus sequence typing. The majority of sequenced isolates (24/27) carried the erm(B) gene and 16/27 also carried the aac(6')-aph(2'') gene with the corresponding antimicrobial susceptibility phenotypes. Nine RT176 strains carried the cfr(E)gene and one RT001 strain carried the cfr(C) gene, but without linezolid resistance. CONCLUSIONS: The newly-predominant RT176 and endemic RT001 are driving the epidemiology of CDI in Slovakia. In addition to fluoroquinolones, the use of macrolide-lincosamide-streptogramin B antibiotics can represent another driving force for the spread of these epidemic lineages. In C. difficile, linezolid resistance should be confirmed phenotypically in strains with detected cfr gene(s).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010913
003      
CZ-PrNML
005      
20230801132707.0
007      
ta
008      
230718s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijantimicag.2023.106824 $2 doi
035    __
$a (PubMed)37116667
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Plankaova, Adriana $u Department of Clinical Microbiology, Unilabs Inc., Roznava, Slovakia
245    10
$a Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-2019 / $c A. Plankaova, M. Brajerova, V. Capek, G. Balikova Novotna, P. Kinross, J. Skalova, A. Soltesova, P. Drevinek, M. Krutova
520    9_
$a AIM: To investigate the epidemiology of Clostridioides difficile infection (CDI) in Slovakian hospitals after the emergence of ribotype 176 (027-like) in 2016. METHODS: Between 2018 and 2019, European Centre for Disease Control and Prevention CDI surveillance protocol v2.3 was applied to 14 hospitals, with additional data collected on recent antimicrobial use and the characterization of C. difficile isolates. RESULTS: The mean hospital incidence of CDI was 4.1 cases per 10,000 patient bed-days. One hundred and five (27.6%) in-hospital deaths were reported among the 381 cases. Antimicrobial treatment within the previous 4 weeks was recorded in 90.5% (333/368) of cases. Ribotype (RT)176 was detected in 50% (n=185/370, 14 hospitals) and RT001 was detected in 34.6% (n=128/370,13/14 hospitals) of cases with RT data. Overall, 86% (n=318/370) of isolates were resistant to moxifloxacin by Thr82Ile in GyrA (99.7%). Multi-locus variable tandem repeat analysis showed clonal relatedness of predominant RTs within and between hospitals. Seven of 14 sequenced RT176 isolates and five of 13 RT001 isolates showed between zero and three allelic differences by whole-genome multi-locus sequence typing. The majority of sequenced isolates (24/27) carried the erm(B) gene and 16/27 also carried the aac(6')-aph(2'') gene with the corresponding antimicrobial susceptibility phenotypes. Nine RT176 strains carried the cfr(E)gene and one RT001 strain carried the cfr(C) gene, but without linezolid resistance. CONCLUSIONS: The newly-predominant RT176 and endemic RT001 are driving the epidemiology of CDI in Slovakia. In addition to fluoroquinolones, the use of macrolide-lincosamide-streptogramin B antibiotics can represent another driving force for the spread of these epidemic lineages. In C. difficile, linezolid resistance should be confirmed phenotypically in strains with detected cfr gene(s).
650    _2
$a lidé $7 D006801
650    _2
$a fluorochinolony $x farmakologie $7 D024841
650    12
$a Clostridioides difficile $x genetika $7 D016360
650    _2
$a ribotypizace $7 D021521
650    _2
$a Clostridioides $x genetika $7 D000082682
650    _2
$a linezolid $7 D000069349
650    _2
$a multilokusová sekvenční typizace $7 D058885
650    _2
$a antibakteriální látky $x farmakologie $x terapeutické užití $7 D000900
650    12
$a klostridiové infekce $x epidemiologie $x farmakoterapie $7 D003015
650    _2
$a makrolidy $7 D018942
650    _2
$a mikrobiální testy citlivosti $7 D008826
651    _2
$a Slovenská republika $x epidemiologie $7 D018154
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brajerova, Marie $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Capek, Vaclav $u Bioinformatics Centre, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Balikova Novotna, Gabriela $u Institute of Microbiology, The Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
700    1_
$a Kinross, Pete $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Skalova, Jana $u Department of Clinical Microbiology, Unilabs Inc., Roznava, Slovakia
700    1_
$a Soltesova, Anna $u Department of Clinical Microbiology, Unilabs Inc., Roznava, Slovakia
700    1_
$a Drevinek, Pavel $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Krutova, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Electronic address: marcela.krutova@lfmotol.cuni.cz
773    0_
$w MED00005050 $t International journal of antimicrobial agents $x 1872-7913 $g Roč. 62, č. 1 (2023), s. 106824
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37116667 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132704 $b ABA008
999    __
$a ok $b bmc $g 1963372 $s 1197178
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 62 $c 1 $d 106824 $e 20230426 $i 1872-7913 $m International journal of antimicrobial agents $n Int J Antimicrob Agents $x MED00005050
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...